TABLE 4.

Comparison between the four IR6 peptides for sensitivity

PanelNo. of serum samplesNo. of positive results (%)a
B31-25IP90-25B31-17IP90-17
Acute, single EM4219 (45.2)*†15 (35.7)*16 (38.0)†15 (35.7)
Acute disseminated, multiple EM53 (60.0)3 (60.0)3 (60.0)3 (60.0)
Acute, neurologic65 (83.3)5 (83.3)5 (83.3)5 (83.3)
Late Lyme disease159 (60.0)‡7 (46.7)‡9 (60.0)9 (60.0)
Lyme disease reinfected55 (100)5 (100)5 (100)5 (100)
Total7341 (56)35 (48)38 (52)37 (51)
  • a *, OR = 1.479; †, OR = 1.292; ‡, OR = 1.683.